FeesSafety
Pluang+

UK investor recovers $4.5M in bitcoin lost for 13 years after exchange shutdown.

Market News
06 Sep 2026
Blockonomi
View Source
Bullish
UK investor recovers $4.5M in bitcoin lost for 13 years after exchange shutdown.

A UK investor named Chris recovered bitcoin worth about $4.5 million after losing access for over 13 years due to the shutdown of the Britcoin/Intersango exchange. He initially bought bitcoin in 2011 for around £1,500 when prices were under $4 per coin. Using blockchain tracing technology, legal experts located a wallet with over 5,500 BTC linked to the defunct exchange, enabling Chris to reclaim his assets. This case shows that lost cryptocurrency from early exchanges can still be recovered with proper legal and technical support.

More News

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...

Market News
Bullish
28 minutes ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...

Market News
Bullish
28 minutes ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...

Market News
Bullish
28 minutes ago
Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...

Market News
Bullish
28 minutes ago
Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...

Market News
Bullish
28 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App